Receive funding for your R&D Projects!
Your partner for subsidy advice
Your partner for subsidy advice
Scientists at Jefferson Medical College have used gene therapy to reverse the progression of Parkinson’s disease in rats. They have found that by adding a gene for an enzyme, they were able to reprogram brain circuitry and halt the deterioration of dopamine producing brain cells, one of the key problems in the disease.
“It’s not just inserting a replacement for a missing or mutated gene as a treatment for a genetic disorder,” says Michael Oshinsky, Ph.D., research assistant professor of neu
A partially exploding star, known as a nova, has recovered more quickly than expected, say scientists who have analysed new data from the ESA`s XMM-Newton X-ray satellite.
Nova explosions are not completely destructive phenomena. In fact, after an explosion occurs, the star recovers and starts shining again. Until now, astronomers have not known how long this process takes. In this case, however, the exploding star recovered in less than three years. This is surprising, given the fact that t
Atorvastatin shown to decrease heart disease and stroke in patients with hypertension and low cholesterol
A major European trial studying different blood pressure treatments and the effects of additional cholesterol lowering, announces today that it has stopped part of its trial earlier than expected because results collected already show a significant benefit to patients on one of its treatments.
It found that among 10,297 patients with hypertension and cholesterol levels lower t
An early version of a new software system developed by University at Buffalo researchers that detects cyberattacks while they are in progress by drawing highly personalized profiles of users has proven successful 94 percent of the time in simulated attacks.
The “user-level anomaly detection system” was described here today (Oct. 10, 2002) at the military communications conference known as MILCOM 2002.
“We have developed a new paradigm, proactively encapsulating user intent where y
High Level Group for Hydrogen and Fuel Cell
Thank you Madam Vice President, and thank you again, (Ladies and) gentlemen for your attention.
Madam de Palacio has presented to you our concerns in the European Union over Global climate change, energy security and transport. We are committed to achieving sustainable development.
We re-stated our commitment in Johannesburg and are embarking on a comprehensive range of measures. This includes research on the most promisi
The first clinical trial to compare directly two of the most widely-used drugs in advanced lung cancer, cisplatinin and carboplatin (both in combination with paclitaxel) – have concluded that the older drug, cisplatin, is the better treatment.
Patients given cisplatin and paclitaxel had better survival rates and their quality of life was just as good as patients receiving carboplatin and paclitaxel.
The phase III multi-national European trial involving 618 patients with advanced non